-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/machine-learning-tools-white-paper.pdf
December 01, 2024 - The interpretation of the results identified the correct treatment and whether
treatment effects were … Testing a Machine Learning Tool for
Facilitating Living Systematic Reviews of
Chronic Pain Treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_technical-brief.pdf
March 01, 2015 - Public reporting may also improve
how health care resources are consumed by promoting the use of treatments … transparency is normally
targeted before consumers seek care so they can be empowered to make informed treatment … , 2011 Agency for Healthcare Research and Quality Original Research X X
Barlas, 2010 Pharmacy and Therapeutics … Pharmacy and
Therapeutics 2010;35(7):369-372.
Catalyst for payment reform. … Within
these care settings, the vendors report on costs for medical treatments, procedures, imaging
-
effectivehealthcare.ahrq.gov/health-topics/ebola
-
effectivehealthcare.ahrq.gov/health-topics/postpartum-depression
-
effectivehealthcare.ahrq.gov/health-topics/stroke
-
effectivehealthcare.ahrq.gov/health-topics/diabetic-eye-problems
-
effectivehealthcare.ahrq.gov/health-topics/hypothyroidism
-
effectivehealthcare.ahrq.gov/health-topics/hyperthyroidism
-
effectivehealthcare.ahrq.gov/health-topics/cervical-cancer
-
effectivehealthcare.ahrq.gov/health-topics/chronic-kidney-disease
-
effectivehealthcare.ahrq.gov/health-topics/breast-cancer
-
effectivehealthcare.ahrq.gov/health-topics/rashes
-
effectivehealthcare.ahrq.gov/health-topics/bronchial-disorders
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
January 24, 2022 - analysis Death within the first 3 months after SARS-CoV-2 infection, active chemotherapy, previous therapy … were included in this analysis Death within the first 3 months after SARS-CoV-2 infection, previous therapy … radiological suspicion of infection, cancer patients at high risk for infection and eligible for active therapy … Severe Obesity: 5 (3.1)*
Immunosuppresssed (e.g., HIV, autoimmune disease): 2 (1.3)*
Immune-weakening therapy … sample was taken)
Median (IQR) days from symptom onset to testing: 6 (3-9) Asymptomatic: 34* (19.2)* Treatment
-
effectivehealthcare.ahrq.gov/health-topics/lymphedema
-
effectivehealthcare.ahrq.gov/health-topics/bowel-incontinence
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-f-1_0.xlsx
January 01, 2016 - 8 in BVM group, 21 in ETI group NR NA 15 8 NA 107 56 NA
Cooper, 2001 2 BVM NR 99 ETI NR 479 Harms Treatment … airway, and video-assisted laryngoscopy. 999 Harms Regurgitation of gastric content Safety population (treatment … laryngeal mask airway, and video-assisted laryngoscopy. 996 Success Failure rate Safety population (treatment … hour
ICU intensive care unit
ILMA Intubating Laryngeal Mask Airway
IPTW inverse probability of treatment
-
effectivehealthcare.ahrq.gov/health-topics/pacemakers-and-implantable-defibrillators
-
effectivehealthcare.ahrq.gov/health-topics/clinical-trials
-
effectivehealthcare.ahrq.gov/health-topics/back-pain